Royal Bank of Canada’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Sell |
5,003
-75
| -1% | -$195 | ﹤0.01% | 6016 |
|
|
2025
Q1 | $7K | Sell |
5,078
-5,097
| -50% | -$7.03K | ﹤0.01% | 5859 |
|
|
2024
Q4 | $20K | Sell |
10,175
-2,743
| -21% | -$5.39K | ﹤0.01% | 5608 |
|
|
2024
Q3 | $40K | Buy |
12,918
+3,479
| +37% | +$10.8K | ﹤0.01% | 5339 |
|
|
2024
Q2 | $30K | Buy |
9,439
+6,409
| +212% | +$20.4K | ﹤0.01% | 5493 |
|
|
2024
Q1 | $14K | Sell |
3,030
-1,000
| -25% | -$4.62K | ﹤0.01% | 5604 |
|
|
2023
Q4 | $7K | Sell |
4,030
-4,055
| -50% | -$7.04K | ﹤0.01% | 6032 |
|
|
2023
Q3 | $8K | Sell |
8,085
-2,039
| -20% | -$2.02K | ﹤0.01% | 5984 |
|
|
2023
Q2 | $22K | Buy |
10,124
+3,121
| +45% | +$6.78K | ﹤0.01% | 5698 |
|
|
2023
Q1 | $14K | Buy |
7,003
+1,373
| +24% | +$2.75K | ﹤0.01% | 5772 |
|
|
2022
Q4 | $21K | Buy |
5,630
+3,639
| +183% | +$13.6K | ﹤0.01% | 5803 |
|
|
2022
Q3 | $9K | Buy |
1,991
+500
| +34% | +$2.26K | ﹤0.01% | 5964 |
|
|
2022
Q2 | $12K | Buy |
1,491
+600
| +67% | +$4.83K | ﹤0.01% | 5826 |
|
|
2022
Q1 | $13K | Buy |
891
+412
| +86% | +$6.01K | ﹤0.01% | 6334 |
|
|
2021
Q4 | $10K | Sell |
479
-398
| -45% | -$8.31K | ﹤0.01% | 6504 |
|
|
2021
Q3 | $24K | Buy |
877
+400
| +84% | +$10.9K | ﹤0.01% | 6079 |
|
|
2021
Q2 | $12K | Buy |
477
+50
| +12% | +$1.26K | ﹤0.01% | 6287 |
|
|
2021
Q1 | $11K | Buy |
+427
| New | +$11K | ﹤0.01% | 6244 |
|
|
2020
Q4 | – | Sell |
-22
| Closed | -$1K | – | 6473 |
|
|
2020
Q3 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 5884 |
|